Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective

M Tomblyn, T Chiller, H Einsele, R Gress… - Bone marrow …, 2009 - nature.com
Guidelines for preventing infectious complications among hematopoietic cell transplant
recipients: a global perspective | Bone Marrow Transplantation Skip to main content Thank you …

[HTML][HTML] Clinical aspects of uncomplicated and severe malaria

A Bartoloni, L Zammarchi - Mediterranean journal of hematology …, 2012 - ncbi.nlm.nih.gov
The first symptoms of malaria, common to all the different malaria species, are nonspecific
and mimic a flu-like syndrome. Although fever represents the cardinal feature, clinical …

Economic burden associated with acute myeloid leukemia treatment

AM Zeidan, D Mahmoud… - Expert review of …, 2016 - Taylor & Francis
The economic burden associated with acute myeloid leukemia (AML) is poorly defined and
understudied. The goal of this study is estimate the direct cost of illness for AML in the United …

Trends of hematopoietic stem cell transplantation in the third millennium

A Gratwohl, H Baldomero - Current opinion in hematology, 2009 - journals.lww.com
HSCT is likely to continue to increase for currently established indications. Indications and
technologies will vary between countries with limited or nonrestricted resources. The most …

Bone marrow transplantation for thalassemia from alternative related donors: improved outcomes with a new approach

J Gaziev, M Marziali, A Isgro, P Sodani… - Blood, The Journal …, 2013 - ashpublications.org
Bone marrow transplantation (BMT) performance can be limited by a lack of ideal donors,
and the role of alternative donor hematopoietic cell transplantation in thalassemia is not well …

[HTML][HTML] Comparing outcomes with bone marrow or peripheral blood stem cells as graft source for matched sibling transplants in severe aplastic anemia across …

R Kumar, F Kimura, KW Ahn, ZH Hu… - Biology of Blood and …, 2016 - Elsevier
Bone marrow (BM) is the preferred graft source for hematopoietic stem cell transplantation
(HSCT) in severe aplastic anemia (SAA) compared with mobilized peripheral blood stem …

Epidemiological, clinical and genetic characterization of aplastic anemia patients in Pakistan

Z Akram, P Ahmed, S Kajigaya, TM Satti, HS Satti… - Annals of …, 2019 - Springer
Aplastic anemia (AA) is the most serious non-malignant blood disorder in Pakistan, ranked
second in prevalence, after thalassemia. We investigated various epidemiological, clinical …

Review of haploidentical hematopoietic cell transplantation

MA Khan, Q Bashir, QN Chaudhry, P Ahmed… - Journal of Global …, 2018 - ascopubs.org
Use of haploidentical (haplo) donors for hematopoietic cell transplantation (HCT) has
significantly increased in the last decade. The major advantage with this strategy is universal …

[HTML][HTML] Probability of finding an HLA-matched donor in immediate and extended families: the Jordanian experience

WM Elbjeirami, F Abdel-Rahman… - Biology of Blood and …, 2013 - Elsevier
Information regarding the probability of finding HLA-matched related donor for a patient
awaiting hematopoietic stem cell transplantation (HSCT) in developing countries is scanty …

ATG vs thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassemia

L Faulkner, C Uderzo, S Khalid, P Marwah… - Blood …, 2017 - ashpublications.org
Matched-related bone marrow transplantation (BMT) may cure> 80% of low-risk children
with severe thalassemia (ST). Very long-term follow-up studies have shown how the …